Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Switzerland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20051
20063
20091
20101
20161
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
International Extranodal Lymphoma Study Group (IELSG)2
Novartis Pharmaceuticals2
Pfizer2
Debiopharm International SA1
Loxo Oncology, Inc.1
Lymphoma Study Association1
Merck KGaA, Darmstadt, Germany1
Sandoz1
Transgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell12
Lymphoma4
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Breast Neoplasms1
Dendritic Cell Sarcoma, Interdigitating1
Febrile Neutropenia1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lung Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.